<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02015923</url>
  </required_header>
  <id_info>
    <org_study_id>01CCRe-IV</org_study_id>
    <secondary_id>2013-001688-22</secondary_id>
    <nct_id>NCT02015923</nct_id>
  </id_info>
  <brief_title>Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases</brief_title>
  <acronym>CCRe-IV</acronym>
  <official_title>Multicenter Randomized Study in Patients With Colorectal Cancer With Unresectable Metastases. Impact of Resection vs no Resection of the Primary Tumour as a Survival Factor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari de Bellvitge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari de Bellvitge</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main outcome: Assess the impact of cancer-related survival at 2 years in patients with
      unresectable metastatic colorectal cancer treated with chemotherapy alone versus surgery
      followed by chemotherapy. To assess overall survival. To evaluate postoperative morbidity and
      mortality in patients treated with resection of the primary tumor. Assess complications and
      meed for surgery in patients treated with systemic chemotherapy only during the course of the
      disease. Identify and describe the complications related to chemotherapy and toxicity in the
      short and medium term systemic treatment. Assessing the quality of life questionnaire QLQ-C30
      and QLQ-CR29. To study prognostic survival factors.

      Method: multicenter randomized clinical trail (22 hospitals). Two parallel group in which to
      evaluate two therapeutic strategies for colorectal cancer metastasis unresectable stage IV:
      chemotherapy alone versus primary tumor resection plus chemotherapy.

      Subjects: patients with unresectable nonmetastatic colorectal cancer. Hypothesis:Surgical
      resection of the primary tumor in stage IV colorectal patients with unresectable synchronous
      metastases increases by 14% overall survival compared to patients receiving systemic
      treatment with chemotherapy without resection of the primary tumor (survival of 34% vs 20%).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intervention: Arm B (control): chemotherapy alone, regimen according to each center. Arm A
      (experimental): surgery (complete tumoral resection; R0) followed by chemotherapy, regimen
      according to each center. Statistical Analysis: A power analysis showed that to assure a
      significance level of 0,05 and a beta error 0.20. 168 patients are necessary in each arm. It
      has been estimated a loss rate of up to 10%.

      Differences between groups will be analyzed by t, U, X2, exact test and survival will be
      assessed according to Kaplan and Meier method. Evaluation of safety of the trial will be made
      in the middle of the study statistically
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess the impact of overall survival in patients with unresectable metastatic colorectal cancer treated with chemotherapy alone vs surgery followed by chemotherapy.</measure>
    <time_frame>up to 2 years</time_frame>
    <description>The percentage of patients who are still alive for follow-up at 2 years after randomization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative morbidity and mortality.</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Postoperative complications were classified according to the Dindo-Clavien classification.
Mortality within 30 days after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications in patients treated with systemic chemotherapy</measure>
    <time_frame>up to 2 years</time_frame>
    <description>The toxicity will be evaluated and documented according to the CTCAE version 4.0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Questionnaire QLQ-C30 (Quality of life) and QLQ-CR29</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study of possible survival factors</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Identify factors that may influence patient survival before applying any treatment (demographics, clinicals and analitycal factors, tumor characteristics; ...)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">336</enrollment>
  <condition>Colonic Cancer</condition>
  <condition>Unresectable Metastasis Originating in Colonic Cancer</condition>
  <arm_group>
    <arm_group_label>colonic resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm A (experimental): surgery (complete tumoral resection; R0) followed by chemotherapy, regimen according to each center.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chemotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm B (control): chemotherapy alone, regimen according to each center</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonic resection</intervention_name>
    <description>Colonic cancer resection, R0 No surgical intervention on metastasis</description>
    <arm_group_label>colonic resection</arm_group_label>
    <arm_group_label>Chemotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chemotherapy- scheme</intervention_name>
    <description>Chemotherapy, specified in each center with or without biological drugs</description>
    <arm_group_label>colonic resection</arm_group_label>
    <arm_group_label>Chemotherapy</arm_group_label>
    <other_name>FOLFOX-4</other_name>
    <other_name>FOLFOX-6</other_name>
    <other_name>FOLFIRI</other_name>
    <other_name>FOLFOXIRI</other_name>
    <other_name>CAPOX</other_name>
    <other_name>CETUXIMAX / BEVACIZUMAB/PANITUMUMAB</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  colorectal cancer above to 12 cm from the anal verge

          -  unresectable synchronous metastases

          -  no contraindications for chemotherapy

          -  absence of peritoneal carcinomatosis, central nervous system o bone metastasis.

          -  performance status ECOG ≤ 2 (Eastern Cooperative Oncology Group)

          -  uncontrolled concomitant medical conditions that may compromise to chemotherapy

          -  significant symptomatic cardiac disease

          -  not pregnancy or breastfeeding

        Exclusion Criteria:

          -  Cases of rectal tumours below 12cm from anal verge, or locally advanced tumours
             invading blood vessels, nerves or bone.

          -  Multiple bone metastasis or central nervous system metastasis

          -  Other neoplastic disease in the 5 previous years, except squamous or basal cell skin
             carcinoma or cervical &quot;in situ&quot; carcinoma

          -  Significant heart disease (chronic congestive heart failure, symptomatic coronary
             disease) or myocardial infarction in the previous 6 months

          -  Peripheral neuropathy

          -  Patients who do not give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastiano Biondo, Sponsor</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitari de Bellvitge</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javier Vaqué</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario La Fe</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan García Armengol</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de Valencia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laura Mora</last_name>
    <role>Principal Investigator</role>
    <affiliation>Corporacion Parc Tauli</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ignasi Camps Ausàs</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Gemans Tiras i Pujol</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miguel Pera Román</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Univesitari del Mar</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduardo Targarona Soler</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lorenzo Viso Pons</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Sant Joan Despí Moisès Broggi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José Manuel Ramírez Rodríguez</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínico Univeristario &quot;Lozano Blesa&quot;</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Julià Bergkvist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari de Girona DrJosep Trueta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Teresa García Martínez</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario Universitario de Vigo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario Álvarez Gallego</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Univerisitario La Paz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José María Enríquez Navascués</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Donostia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando de la Portilla de Juan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospitales Universitarios Virgen del Rocío</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miguel Angel Ciga</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario de Navarra</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eloy Espín Basany</last_name>
    <role>Principal Investigator</role>
    <affiliation>hospital Universitari de la Vall D'Hebron</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Ferrer Márquez</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario Torrecárdenas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jesús Abrisqueta Carrión</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínico Universitario Virgen de la Arrixaca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José Errasti Alustiza</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Araba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alberto Parajó Calvo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario Universitario de Orense</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Moreno Sanz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario La Mancha Centro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alejando Espí Macías</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínico Universitario de Valencia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sebastiano Biondo, Principal investigator</last_name>
    <phone>0034932607485</phone>
    <email>sbn.biondo@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ricardo Frago, associate investigator</last_name>
    <phone>0034932607485</phone>
    <email>rfrago@bellvitgehospital.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario Araba</name>
      <address>
        <city>Vitoria/Gasteiz</city>
        <state>Araba</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari de Bellvitge</name>
      <address>
        <city>L'Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08709</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastiano Biondo, Principal investigator</last_name>
      <phone>0034932607485</phone>
      <email>sbn.biondo@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ricardo Frago, associate investigator</last_name>
      <phone>0034932607485</phone>
      <email>rfrago@bellvitgehospital.cat</email>
    </contact_backup>
    <investigator>
      <last_name>Sebastiano Biondo</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ricardo Frago</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Corporació Sanitària Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Moisès Broggi</name>
      <address>
        <city>Sant Joan Despí</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario La Mancha Centro</name>
      <address>
        <city>Alcazar de San Juan</city>
        <state>Ciudad Real</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlos Moreno Sanz</last_name>
    </contact>
    <investigator>
      <last_name>Carlos Moreno Sanz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miguel Ángel Ciga</last_name>
    </contact>
    <investigator>
      <last_name>Miguel Ángel Ciga</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Vigo</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Teresa García Martínez</last_name>
    </contact>
    <investigator>
      <last_name>Teresa García Martínez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Torrecárdenas</name>
      <address>
        <city>Almería</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manuel Ferrer Márquez</last_name>
    </contact>
    <investigator>
      <last_name>Manuel Ferrer Márquez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eduardo Targarona Soler</last_name>
    </contact>
    <investigator>
      <last_name>Eduardo Targarona Soler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Univesitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Donostia</name>
      <address>
        <city>Donostia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Máría Enríquez Navascués</last_name>
    </contact>
    <investigator>
      <last_name>José Máría Enríquez Navascués</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari de Girona DrJosep Trueta</name>
      <address>
        <city>Girona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Julià Bergkvist</last_name>
    </contact>
    <investigator>
      <last_name>David Julià Bergkvist</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Univerisitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marío Álvarez Gallego</last_name>
    </contact>
    <investigator>
      <last_name>Mario Álvarez Gallego</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Orense</name>
      <address>
        <city>Ourense</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Parajó Calvo</last_name>
    </contact>
    <investigator>
      <last_name>Alberto Parajo Calvo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fernando de la Portilla de Juan</last_name>
    </contact>
    <investigator>
      <last_name>Fernando de la Portilla de Juan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alejandro Espí Macias</last_name>
    </contact>
    <investigator>
      <last_name>Alejandro Espí Macias</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan García Armengol</last_name>
    </contact>
    <investigator>
      <last_name>Juan García Armengol</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari i Politècnic la Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Javier Vaqué</last_name>
    </contact>
    <investigator>
      <last_name>Javier Vaqué</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Univeristario &quot;Lozano Blesa&quot;</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Manuel Ramírez Rodríguez</last_name>
    </contact>
    <investigator>
      <last_name>José Manuel Ramírez Rodríguez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2013</study_first_submitted>
  <study_first_submitted_qc>December 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2013</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitari de Bellvitge</investigator_affiliation>
    <investigator_full_name>Sebastiano Biondo</investigator_full_name>
    <investigator_title>Phd, MD</investigator_title>
  </responsible_party>
  <keyword>Colonic cancer</keyword>
  <keyword>Metastasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

